Published in Am J Clin Pathol on September 01, 1975
Genetic epidemiology, hematological and clinical features of hemoglobinopathies in Iran. Biomed Res Int (2013) 0.87
Studies of an unusual hemoglobin in patients with diabetes mellitus. Biochem Biophys Res Commun (1969) 1.78
An abnormal hemoglobin in red cells of diabetics. Clin Chim Acta (1968) 1.76
Two haemoglobins Q, alpha-74 (EF3) and alpha-75 (EF4) aspartic acid to histidine. Br J Haematol (1970) 1.28
Discrimination among the transcripts of the allelic human beta-globin genes beta A, beta S and beta C using oligodeoxynucleotide hybridization probes. Gene (1986) 1.20
Haemoglobin D Iran: 2 22 glutamic acid leads to glutamine (B4). Br J Haematol (1973) 1.07
A new advanced glycation inhibitor, LR-90, prevents experimental diabetic retinopathy in rats. Br J Ophthalmol (2008) 0.94
LR16, a compound with potent effects on the oxygen affinity of hemoglobin, on blood cholesterol, and on low density lipoprotein. Proc Natl Acad Sci U S A (1988) 0.89
Abnormal haemoglobins in Iran. Observation of a new variant--haemoglobin J Iran (alpha-2-beta-2 77 His--Asp). Br Med J (1967) 0.88
LR-90 prevents dyslipidaemia and diabetic nephropathy in the Zucker diabetic fatty rat. Diabetologia (2008) 0.88
Hemoglobin Setif (alpha94 (G1) Asp replaced by Tyr) in Iram. A report of 9 cases. Hemoglobin (1977) 0.87
LR-90 a new advanced glycation endproduct inhibitor prevents progression of diabetic nephropathy in streptozotocin-diabetic rats. Diabetologia (2003) 0.87
Hemoglobin Lepore Boston in two Iranian families. Blood (1974) 0.85
Carcinogenicity and haemoglobin synthesis induction by cytidine analogues. Br J Cancer (1988) 0.85
Haplotype analysis of the human beta-globin gene complex using multiple locus specific oligonucleotide probes. Anal Biochem (1988) 0.85
Routine laser assisted hatching results in significantly increased clincal pregnancies. J Assist Reprod Genet (2003) 0.84
Fetal hemoglobin gene activation in a phase II study of 5,6-dihydro-5-azacytidine for bronchogenic carcinoma. Cancer Res (1987) 0.82
Mild sickle cell anemia associated with alpha globin mutant alpha Montgomery. Am J Med (1989) 0.80
Reverse phase high-performance liquid chromatography and secondary ion mass spectrometry. A strategy for identification of ten human hemoglobin variants. Hemoglobin (1986) 0.80
Molecular analyses of beta-thalassemia in Iran. Hemoglobin (1995) 0.80
Hemoglobin H disease in two Iranian families. Clin Chim Acta (1968) 0.80
A case of homozygous haemoglobin Lepore Boston in Iran. Acta Haematol (1975) 0.79
Effects of a new advanced glycation inhibitor, LR-90, on mitigating arterial stiffening and improving arterial elasticity and compliance in a diabetic rat model: aortic impedance analysis. Br J Pharmacol (2014) 0.79
Haemoglobin Daneshgah-Tehran alpha2 72 (EPI) histidine--arginine betaA2. Nat New Biol (1973) 0.77
PACAP mediates the neural proliferative pathway of Mastomys enterochromaffin-like cell transformation. Regul Pept (2001) 0.77
Glycosylated hemoglobins. Tex Rep Biol Med (1982) 0.76
A silent hemoglobin variant detected by HPLC: hemoglobin City of Hope beta 69 (E13) Gly----Ser. Hemoglobin (1984) 0.76
Hemoglobin D Punjab in a Bulgarian Jewish family. Isr J Med Sci (1970) 0.76
Hemoglobin North Chicago (beta 36 [C2] proline----serine): a new high affinity hemoglobin. Hemoglobin (1985) 0.75
Hemoglobinopathies in the Los Angeles area. Hemoglobin (1983) 0.75
Immunochemical studies in a patient with Waldenstrom's macroglobulinemia. Acta Med Iran (1978) 0.75
A second case of hemoglobin McKees Rocks (beta 145 Tyr leads to Term). A variant with premature termination of the beta-chain. Hemoglobin (1983) 0.75
Haemoglobin Avicenna (beta 47 (CD6) Asp replaced by Ala). A new abnormal haemoglobin. Biochim Biophys Acta (1979) 0.75
Splice junction [IVS-II-1 (G-->C)] thalassemia; a new mutation detected in an Iranian patient. Hemoglobin (1993) 0.75
Indirect allosteric effects of a neutral mutation. Structure of deoxyhaemoglobin north Chicago (ProC2(36)beta----Ser). J Mol Biol (1988) 0.75
Heterogeneous ontogeny of erythropoiesis after bone marrow ablation and allogeneic bone marrow grafting. Blood (1983) 0.75
Two new haemoglobins: haemoglobin Perspolis (alpha 64 (E13) Asp leads to Tyr) and haemoglobin J-Kurosh (alpha 19 (AB) Ala leads to Asp). Biochim Biophys Acta (1976) 0.75
Functional studies, anion-binding and effects of bezafibrate on three high affinity hemoglobin variants: Hb Olympia, Hb Great Lakes and Hb North Chicago. Hemoglobin (1986) 0.75
Hemoglobin Osu-Christiansborg (beta52 (D3) Aspyield Asn) in an Iranian family. Hemoglobin (1978) 0.75
Hemoglobin Great Lakes (beta 68 [E12] leucine replaced by histidine): a new high-affinity hemoglobin. Blood (1981) 0.75
Hemoglobin Hammersmith (beta 42 (CD1) Phe replaced by Ser) associated with severe hemolytic anemia. Hemoglobin (1981) 0.75
Glycosylated minor C, D, and E hemoglobins. Biochem Med (1981) 0.75
Haemoglobin Arya: alpha 2-47 (CD5), aspartic acid yields asparagine. Biochim Biophys Acta (1975) 0.75
Iron overload in three generations of a family with hemoglobin Olympia. Gastroenterology (1984) 0.75
Haemoglobin hamadan: alpha-2A beta-2 56 (D7) glycine yields arginine. Biochim Biophys Acta (1975) 0.75
Hemoglobin Hammersmith as the cause of severe hemolytic anemia in a Chinese girl. Am J Pediatr Hematol Oncol (1986) 0.75
Haemoglobin L Persian Gulf: alpha-57 (E6) glycine leads to arginine. Acta Haematol (1969) 0.75
Haemoglobin M Boston in an Iranian family. Acta Med Iran (1977) 0.75
Glycosylated hemoglobins. History, biochemistry, and clinical implications. N Y State J Med (1980) 0.75
Microcytosis in Hodgkin disease associated with unbalanced globin chain synthesis. Am J Hematol (1986) 0.75
Favism in the Caspian littoral area of Iran. Trop Geogr Med (1971) 0.75
Haemoglobin Coventry (beta 141 deleted) in Iran. FEBS Lett (1978) 0.75